Journal article
Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.
Abstract
BACKGROUND: The optimal duration of prophylaxis against venous thromboembolism after total hip or knee replacement is uncertain.
OBJECTIVE: To determine the efficacy and safety of extended out-of-hospital prophylaxis with low-molecular-weight heparin (ardeparin sodium).
Authors
Heit JA; Elliott CG; Trowbridge AA; Morrey BF; Gent M; Hirsh J
Journal
Annals of Internal Medicine, Vol. 132, No. 11, pp. 853–861
Publisher
American College of Physicians
Publication Date
June 6, 2000
DOI
10.7326/0003-4819-132-11-200006060-00002
ISSN
1056-8751